English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Characterization of the TBR1 interactome: Variants associated with neurodevelopmental disorders disrupt novel protein interactions

MPS-Authors
/persons/resource/persons187603

Sollis,  Elliot
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;

/persons/resource/persons212529

Den Hoed,  Joery
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;

/persons/resource/persons71764

Estruch,  Sara Busquets
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;

/persons/resource/persons146129

Vino,  Arianna
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;

/persons/resource/persons32809

Derizioti,  Pelagia
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;

/persons/resource/persons4427

Fisher,  Simon E.
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;
Donders Institute for Brain, Cognition and Behaviour, External Organizations;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
Supplementary Material (public)
Citation

Sollis, E., Den Hoed, J., Quevedo, M., Estruch, S. B., Vino, A., Dekkers, D. H. W., et al. (2023). Characterization of the TBR1 interactome: Variants associated with neurodevelopmental disorders disrupt novel protein interactions. Human Molecular Genetics, 32(9): ddac311, pp. 1497-1510. doi:10.1093/hmg/ddac311.


Cite as: https://hdl.handle.net/21.11116/0000-000C-1BED-C
Abstract
TBR1 is a neuron-specific transcription factor involved in brain development and implicated in a neurodevelopmental disorder (NDD) combining features of autism spectrum disorder (ASD), intellectual disability (ID) and speech delay. TBR1 has been previously shown to interact with a small number of transcription factors and co-factors also involved in NDDs (including CASK, FOXP1/2/4 and BCL11A), suggesting that the wider TBR1 interactome may have a significant bearing on normal and abnormal brain development. Here we have identified approximately 250 putative TBR1-interaction partners by affinity purification coupled to mass spectrometry. As well as known TBR1-interactors such as CASK, the identified partners include transcription factors and chromatin modifiers, along with ASD- and ID-related proteins. Five interaction candidates were independently validated using bioluminescence resonance energy transfer assays. We went on to test the interaction of these candidates with TBR1 protein variants implicated in cases of NDD. The assays uncovered disturbed interactions for NDD-associated variants and identified two distinct protein-binding domains of TBR1 that have essential roles in protein–protein interaction.